Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,431 | -27,035 | -3,708 | -164,574 | -100,190 |
| Depreciation Amortization | 1,410 | 938 | 486 | 2,826 | 2,324 |
| Accounts receivable | N/A | N/A | N/A | N/A | 29 |
| Accounts payable and accrued liabilities | -1,898 | -4,075 | -198 | 5,133 | -3,556 |
| Other Working Capital | -2,874 | -6,787 | -2,864 | 5,055 | -1,202 |
| Other Operating Activity | -44,661 | -23,806 | -24,814 | 41,853 | 11,450 |
| Operating Cash Flow | $-81,454 | $-60,765 | $-31,098 | $-109,707 | $-91,145 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 302 | 302 | -24,669 | 36,049 | 36,049 |
| PPE Investments | 125 | 125 | 29 | 1,288 | -234 |
| Investing Cash Flow | $427 | $427 | $-24,640 | $37,337 | $35,815 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -65 | -62 |
| Common Stock Issued | 115 | 115 | N/A | 43,527 | 144 |
| Other Financing Activity | -339 | -339 | -265 | 0 | 0 |
| Financing Cash Flow | $-224 | $-224 | $-265 | $43,462 | $82 |
| Beginning Cash Position | 141,645 | 141,645 | 141,645 | 170,553 | 170,553 |
| End Cash Position | 60,394 | 81,083 | 85,642 | 141,645 | 115,305 |
| Net Cash Flow | $-81,251 | $-60,562 | $-56,003 | $-28,908 | $-55,248 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,454 | -60,765 | -31,098 | -109,707 | -91,145 |
| Capital Expenditure | N/A | N/A | N/A | -272 | -234 |
| Free Cash Flow | -81,454 | -60,765 | -31,098 | -109,979 | -91,379 |